Democratic Sen. Patty Murray of Washington, the ranking member of the Senate committee, charged with confirming oncologist Stephen Hahn as the new commissioner of the US Food and Drug Administration (FDA) later this month, promised to vet the physician on prioritizing scientific principles.
A confirmation hearing for Hahn, President Trump's pick to o take over leadership at the FDA who currently serves as chairman of the MD Anderson Cancer Center's radiation department, is...